India
First point of contact for partners seeking to manufacture cell culture-based therapies more efficiently Draws on multidisciplinary team of experts Dri...
October 03, 2024 | News
Non-exclusive voluntary license agreement enables the manufacture and distribution of lenacapavir for HIV prevention and treatment of heavily treatment-exp...
October 03, 2024 | News
Recipients’ research advances future development of oncology diagnostics, the impact of DNA quality on ovarian cancer outcomes and molecular diagnosi...
September 12, 2024 | News
Hilleman Laboratories, in partnership with Bharat Biotech,announced the successful launch of HILLCHOL®, a groundbreaking oral cholera vaccine (OCV) t...
August 28, 2024 | News
Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED) proudly announces the successful completion of its Phase 1 clinical trial for its flagship prod...
August 28, 2024 | News
Malaria is a life-threatening public health issue, particularly in low- and middle-income countries. There is a need for an effective, affordable, ...
August 21, 2024 | News
Fischer Medical Ventures Ltd (formerly known as Fischer Chemic Limited), through its wholly owned subsidiary Time Medical International Ventures (India) Pr...
July 26, 2024 | News
The program will enhance the development of oncology care, thereby, advancing healthcare landscape of the region Participants will engage in in-depth di...
June 27, 2024 | News
In an interview with BioPharma APAC, Ashok Kumar, Head of BIO4C Commercial at Merck Life Science (Asia Pacific), shares insights on what se...
June 24, 2024 | Interaction
Olympus Corporation , a global MedTech Company committed to making people’s lives healthier, safer and more fulfilling, today announced its stra...
June 12, 2024 | News
Enzene Biosciences, a leading global CDMO known for its flagship fully-connected continuous manufacturing platform (EnzeneXTM) today announces the launch o...
May 30, 2024 | News
BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced a new partnership with Glenmark Specialty S.A. (Glen...
May 21, 2024 | News
- With this investment, SII will acquire 20% stake in IntegriMedical -  ...
May 20, 2024 | News
The agreement aims to supply ImmunityBio with Bacillus Calmette-Guerin (BCG), a critical component in cancer treatment. Under the collaboration, the ...
May 06, 2024 | News
Most Read
Bio Jobs
News